These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 8026557

  • 1. 5-HT1C receptor-mediated phosphoinositide hydrolysis in the rat choroid plexus after chronic treatment with clozapine.
    Kuoppamäki M, Pälvimäki EP, Syvälahti E, Hietala J.
    Eur J Pharmacol; 1994 Apr 01; 255(1-3):91-7. PubMed ID: 8026557
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Chronic clozapine treatment decreases 5-hydroxytryptamine1C receptor density in the rat choroid plexus: comparison with haloperidol.
    Kuoppamäki M, Seppälä T, Syvälahti E, Hietala J.
    J Pharmacol Exp Ther; 1993 Mar 01; 264(3):1262-7. PubMed ID: 8383744
    [Abstract] [Full Text] [Related]

  • 4. Modulation of 5-HT1C receptors and phosphoinositide system by ethanol consumption in rat brain and choroid plexus.
    Pandey SC, Dubey MP, Piano MR, Schwertz DW, Davis JM, Pandey GN.
    Eur J Pharmacol; 1993 Sep 15; 247(1):81-8. PubMed ID: 8258364
    [Abstract] [Full Text] [Related]

  • 5. Serotonin agonists increase transferrin levels via activation of 5-HT1C receptors in choroid plexus epithelium.
    Esterle TM, Sanders-Bush E.
    J Neurosci; 1992 Dec 15; 12(12):4775-82. PubMed ID: 1334504
    [Abstract] [Full Text] [Related]

  • 6. Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists.
    Kuoppamäki M, Syvälahti E, Hietala J.
    Eur J Pharmacol; 1993 Apr 15; 245(2):179-82. PubMed ID: 8387927
    [Abstract] [Full Text] [Related]

  • 7. Chronic citalopram and fluoxetine treatments upregulate 5-HT2c receptors in the rat choroid plexus.
    Laakso A, Pälvimäki EP, Kuoppamäki M, Syvälahti E, Hietala J.
    Neuropsychopharmacology; 1996 Aug 15; 15(2):143-51. PubMed ID: 8840350
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
    Appel NM, Mitchell WM, Garlick RK, Glennon RA, Teitler M, De Souza EB.
    J Pharmacol Exp Ther; 1990 Nov 15; 255(2):843-57. PubMed ID: 2243353
    [Abstract] [Full Text] [Related]

  • 11. Combined treatment with citalopram and buspirone: effects on serotonin 5-HT2A and 5-HT2C receptors in the rat brain.
    Syvälahti E, Penttilä J, Majasuo H, Pälvimäki EP, Laakso A, Hietala J.
    Pharmacopsychiatry; 2006 Jan 15; 39(1):1-8. PubMed ID: 16453246
    [Abstract] [Full Text] [Related]

  • 12. (+/-)-1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane(DOI) and alpha-methyl-5-HT: 5-HT2 receptor agonistic action on phosphatidylinositol metabolism in the rat fronto-cingulate and entorhinal cortex.
    Edwards E, Ashby CR, Wang RY.
    Neuropharmacology; 1992 Jul 15; 31(7):615-21. PubMed ID: 1407401
    [Abstract] [Full Text] [Related]

  • 13. Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroid plexus after fluoxetine and citalopram treatments.
    Pälvimäki EP, Majasuo H, Syvälahti E, Hietala J.
    Pharmacol Res; 2005 May 15; 51(5):419-25. PubMed ID: 15749456
    [Abstract] [Full Text] [Related]

  • 14. 5-HT1C receptors mediate phosphoinositide turnover activation in the immature rat hippocampus.
    Claustre Y, Eudeline B, Benavides J, Scatton B.
    Eur J Pharmacol; 1992 Jan 14; 225(1):37-41. PubMed ID: 1311687
    [Abstract] [Full Text] [Related]

  • 15. The antimigraine drugs ergotamine and dihydroergotamine are potent 5-HT1C receptor agonists in piglet choroid plexus.
    Brown AM, Patch TL, Kaumann AJ.
    Br J Pharmacol; 1991 Sep 14; 104(1):45-8. PubMed ID: 1786517
    [Abstract] [Full Text] [Related]

  • 16. Sertindole is a serotonin 5-HT2c inverse agonist and decreases agonist but not antagonist binding to 5-HT2c receptors after chronic treatment.
    Hietala J, Kuonnamäki M, Pälvimäki EP, Laakso A, Majasuo H, Syvälahti E.
    Psychopharmacology (Berl); 2001 Sep 14; 157(2):180-7. PubMed ID: 11594443
    [Abstract] [Full Text] [Related]

  • 17. [125I]LSD labels 5-HT1C recognition sites in pig choroid plexus membranes. Comparison with [3H]mesulergine and [3H]5-HT binding.
    Hoyer D, Srivatsa S, Pazos A, Engel G, Palacios JM.
    Neurosci Lett; 1986 Sep 12; 69(3):269-74. PubMed ID: 3763057
    [Abstract] [Full Text] [Related]

  • 18. Phosphoinositide hydrolysis linked 5-HT2 receptors in fibroblasts from choroid plexus.
    Barker EL, Burris KD, Sanders-Bush E.
    Brain Res; 1991 Jun 28; 552(2):330-2. PubMed ID: 1655172
    [Abstract] [Full Text] [Related]

  • 19. Chronic effects of imipramine and lithium on 5-HT receptor subtypes in rat frontal cortex, hippocampus and choroid plexus: quantitative receptor autoradiographic analysis.
    Mizuta T, Segawa T.
    Jpn J Pharmacol; 1989 Jul 28; 50(3):315-26. PubMed ID: 2761132
    [Abstract] [Full Text] [Related]

  • 20. [125I]SCH 23982, a 'selective' D-1 receptor antagonist, labels with high affinity 5-HT1C sites in pig choroid plexus.
    Hoyer D, Karpf A.
    Eur J Pharmacol; 1988 May 20; 150(1-2):181-4. PubMed ID: 3402537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.